Impact of noncoding <scp>RNAs</scp> on cancer directed immune therapies: Now then and forever-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of noncoding RNAs on cancer directed immune therapies: Now then and forever

Published:2022-06-08 Issue:7 Volume:151 Page:981-992
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Roy Roshan Kumar¹,Yadav Rakhi¹,Sharma Uttam²,Wasson Mishi Kaushal¹,Sharma Ashok³,Tanwar Pranay⁴,Jain Aklank²,Prakash Hridayesh¹^ORCID

Affiliation:

1. Amity Institute of Virology and Immunology Amity University India Noida India

2. Department of Zoology Central University of Punjab Bathinda India

3. Department of Biochemistry All India Institute of Medical Sciences New Delhi India

4. Laboratory Oncology Unit, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital All India Institute of Medical Sciences New Delhi India

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34060

Reference159 articles.

1. Cytokines in Cancer Immunotherapy

2. Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them

3. Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis

4. Inflammation-Associated Cancer Development in Digestive Organs: Mechanisms and Roles for Genetic and Epigenetic Modulation

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics Analysis of LINC00917 Targets miR-3690/DDX39A Axis to Exacerbate Pancreatic Cancer Cell Growth Using Real-Time Quantitative Reverse Transcription PCR;Journal of Biomedical Nanotechnology;2024-10-01

2. Non-Coding RNAs and Innate Immune Responses in Cancer;Biomedicines;2024-09-11

3. SnoRNAs: the promising targets for anti-tumor therapy;Journal of Pharmaceutical Analysis;2024-08

4. Non‐coding RNAs and their potential exploitation in cancer therapy‐related cardiotoxicity;British Journal of Pharmacology;2024-05-27

5. Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy;International Journal of Nanomedicine;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3